Both in Pharmaceuticals
Travere Therapeutics vs Liquidia
Over the past year TVTX returned +51.7% and LQDA returned +93.2%; their daily moves had a correlation of 0.16.
TVTX +51.7% LQDA +93.2%Growth of $1, one year, split-adjusted
| Metric | TVTX | LQDA |
|---|---|---|
| Price | $52.40 | $48.72 |
| Market cap | $4.94B | $4.36B |
| Today | +6.04% | +15.44% |
| 1 month | −6.4% | +88.0% |
| 6 months | +17.1% | +15.6% |
| Year to date | +37.1% | +41.2% |
| 1 year | +51.7% | +93.2% |
| Revenue growth (YoY) | +36.2% | +1842.7% |
| Gross margin | 98.7% | 93.3% |
| Net margin | −23.3% | 43.5% |
| P/E (TTM) | — | 31.5× |
| Price / sales | 7.6× | 9.7× |
| Net cash | -$131.7M | $108.1M |
| Dividend yield | — | — |
| Volatility (60d) | 37.7% | 192.3% |
| Short % of float | 12.1% | 26.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).